Abstract 1770: A new DOT1L inhibitor with in vivo activity in mouse models of MLL-translocated leukemia
Year: 2020
Type: conference-abstract
Source: Cancer Research
Institutions: Novartis (Switzerland), Novartis (United States), Broad Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3082376233
